Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2012 Feb 01;1654:965-77. doi: 10.1111/j.1476-5381.2011.01615.x.
Show Gene links
Show Anatomy links
Flavan-3-ol esters: new agents for exploring modulatory sites on GABA(A) receptors.
Fernandez SP, Karim N, Mewett KN, Chebib M, Johnston GA, Hanrahan JR.
???displayArticle.abstract???
Enhancement of GABAergic function is the primary mechanism of important therapeutic agents such as benzodiazepines, barbiturates, neurosteroids, general anaesthetics and some anticonvulsants. Despite their chemical diversity, many studies have postulated that these agents may bind at a common or overlapping binding site, or share an activation domain. Similarly, we found that flavan-3-ol esters act as positive modulators of GABA(A) receptors, and noted that this action resembled the in vitro profile of general anaesthetics. In this study we further investigated the interactions between these agents.Using two-electrode voltage clamp electrophysiological recordings on receptors of known subunit composition expressed in Xenopus oocytes, we evaluated positive modulation by etomidate, loreclezole, diazepam, thiopentone, 5α-pregnan-3α-ol-20-one (THP) and the flavan-3-ol ester 2S,3R-trans 3-acetoxy-4'-methoxyflavan (Fa131) on wild-type and mutated GABA(A) receptors.The newly identified flavan, 2S,3S-cis 3-acetoxy-3',4'-dimethoxyflavan (Fa173), antagonized the potentiating actions of Fa131, etomidate and loreclezole at α1β2 and α1β2γ2L GABA(A) receptors. Furthermore, Fa173 blocked the potentiation of GABA responses by high, but not low, concentrations of diazepam, but did not block the potentiation induced by propofol, the neurosteroid THP or the barbiturate thiopental. Mutational studies on 'anaesthetic-influencing' residues showed that, compared with wild-type GABA(A) receptors, α1M236Wβ2γ2L and α1β2N265Sγ2L receptors are resistant to potentiation by etomidate, loreclezole and Fa131.Fa173 is a selective antagonist that can be used for allosteric modulation of GABA(A) receptors. Flavan-3-ol derivatives are potential ligands for etomidate/loreclezole-related binding sites at GABA(A) receptors and the low-affinity effects of diazepam are mediated via the same site.
Akk,
Mutations of the GABA-A receptor alpha1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids.
2008, Pubmed
Akk,
Mutations of the GABA-A receptor alpha1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids.
2008,
Pubmed Alexander,
Guide to Receptors and Channels (GRAC), 5th edition.
2011,
Pubmed Belelli,
The interaction of general anaesthetics and neurosteroids with GABA(A) and glycine receptors.
1999,
Pubmed
,
Xenbase Belelli,
The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid.
1997,
Pubmed
,
Xenbase Belelli,
Neurosteroids: endogenous regulators of the GABA(A) receptor.
2005,
Pubmed Campagna-Slater,
Anaesthetic binding sites for etomidate and propofol on a GABAA receptor model.
2007,
Pubmed Chang,
A single M1 residue in the beta2 subunit alters channel gating of GABAA receptor in anesthetic modulation and direct activation.
2003,
Pubmed
,
Xenbase Desai,
Gamma-amino butyric acid type A receptor mutations at beta2N265 alter etomidate efficacy while preserving basal and agonist-dependent activity.
2009,
Pubmed
,
Xenbase Dixon,
Targeted deletion of the GABRA2 gene encoding alpha2-subunits of GABA(A) receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates.
2008,
Pubmed Drafts,
Identification of structures within GABAA receptor alpha subunits that regulate the agonist action of pentobarbital.
2006,
Pubmed Fernandez,
Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice.
2008,
Pubmed
,
Xenbase Gardner,
Functional in vivo correlates of the benzodiazepine agonist-inverse agonist continuum.
1988,
Pubmed Groves,
The role of GABAbeta2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole.
2006,
Pubmed Hall,
6-Methylflavanone, a more efficacious positive allosteric modulator of gamma-aminobutyric acid (GABA) action at human recombinant alpha2beta2gamma2L than at alpha1beta2gamma2L and alpha1beta2 GABA(A) receptors expressed in Xenopus oocytes.
2005,
Pubmed
,
Xenbase Hill-Venning,
Subunit-dependent interaction of the general anaesthetic etomidate with the gamma-aminobutyric acid type A receptor.
1997,
Pubmed
,
Xenbase Hoffman,
Flumazenil: a benzodiazepine antagonist.
1993,
Pubmed Hosie,
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites.
2006,
Pubmed Ito,
Prediction of the therapeutic dose for benzodiazepine anxiolytics based on receptor occupancy theory.
1997,
Pubmed Ito,
Classification of benzodiazepine hypnotics in humans based on receptor occupancy theory.
1993,
Pubmed Johnston,
GABA(A) receptor channel pharmacology.
2005,
Pubmed Jurd,
General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit.
2003,
Pubmed Krasowski,
Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane.
1998,
Pubmed Li,
Numerous classes of general anesthetics inhibit etomidate binding to gamma-aminobutyric acid type A (GABAA) receptors.
2010,
Pubmed Li,
Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog.
2006,
Pubmed Little,
Differential effects of the benzodiazepine antagonist Ro 15-1788 after "general anaesthetic" doses of benzodiazepines in mice.
1984,
Pubmed Malherbe,
GABAA-receptor expressed from rat brain alpha- and beta-subunit cDNAs displays potentiation by benzodiazepine receptor ligands.
1990,
Pubmed
,
Xenbase McKernan,
Which GABAA-receptor subtypes really occur in the brain?
1996,
Pubmed Mennerick,
Selective antagonism of 5alpha-reduced neurosteroid effects at GABA(A) receptors.
2004,
Pubmed
,
Xenbase Mewett,
Synthesis and biological evaluation of flavan-3-ol derivatives as positive modulators of GABAA receptors.
2009,
Pubmed Miller,
Binding, activation and modulation of Cys-loop receptors.
2010,
Pubmed Möhler,
A new benzodiazepine pharmacology.
2002,
Pubmed Nury,
X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel.
2011,
Pubmed Reynolds,
Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms.
2003,
Pubmed Rudolph,
Molecular and neuronal substrates for general anaesthetics.
2004,
Pubmed Schechter,
Specific antagonism of the behavioral effects of chlordiazepoxide and pentobarbital in the rat.
1984,
Pubmed Siegwart,
Mutational analysis of molecular requirements for the actions of general anaesthetics at the gamma-aminobutyric acidA receptor subtype, alpha1beta2gamma2.
2003,
Pubmed Simon,
Analysis of the set of GABA(A) receptor genes in the human genome.
2004,
Pubmed Stevenson,
beta-Carboline gamma-aminobutyric acidA receptor inverse agonists modulate gamma-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site.
1995,
Pubmed
,
Xenbase Stewart,
Tryptophan mutations at azi-etomidate photo-incorporation sites on alpha1 or beta2 subunits enhance GABAA receptor gating and reduce etomidate modulation.
2008,
Pubmed
,
Xenbase Thompson,
Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination.
1996,
Pubmed
,
Xenbase Wafford,
A novel allosteric modulatory site on the GABAA receptor beta subunit.
1994,
Pubmed
,
Xenbase Walters,
Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms.
2000,
Pubmed
,
Xenbase Wingrove,
The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit.
1994,
Pubmed
,
Xenbase
